Targeting the SETD2-FTO-KIT pathway as a pharmacological strategy for TKI-refractory GIST.

imatinib - Generic mfg.

Comtan (entacapone) - Novartis, Orion Corp

http://www.ncbi.nlm.nih.gov/pubmed/42764990

Anfeng Jiang; Bin Li; Heli Liu; Hengyi Xiao; Jian Tian; Jie Gao; Junju He; Liyu Liu; Lunquan Sun; Shishan Zhou; Xiaowei Liu; Yidi Guan; Yongwei Zhu; Yuezhen Deng; Yumei Duan; Zhen Cao; Zhi Li; Zhuoxian Rong

Sep 22, 2026